Get 20% lifetime commission for referring investors to digrin.com
here.
Grace Therapeutics, Inc. ( GRCE) - Key Metrics
GRCE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0 | -$0.91 | -$0.19 | -$0.19 |
| 2026Q4 | $0 | -$0.07 | -$0.10 | -$0.10 |
| 2026Q3 | $0 | -$0.19 | -$0.13 | -$0.13 |
| 2026Q2 | $0 | -$0.08 | -$0.20 | -$0.20 |
| 2026Q1 | $0 | -$0.21 | -$0.11 | -$0.11 |
GRCE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -0.62 |
| 2026Q4 | 0% | -15.75 |
| 2026Q3 | 0% | -4.55 |
| 2026Q2 | 0% | -9.06 |
| 2026Q1 | 0% | -3.54 |
GRCE
Price: $1.89
52 week price:
Earnings Per Share: -1.17 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 33.6 million